back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Recent filings | ||||||
| Filed 2026-10-07 20:49 Tx date 2026-10-01 |
$ABUS
Arbutus Biopharma Corporation |
Beardsley, Robert Alan
4 - Director of Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$-89,740
-17,948 vol $5.00 each |
14,328 | |
| Older filings | ||||||
| Filed 2026-09-23 21:56 Tx date 2026-09-18 |
$ABUS
Arbutus Biopharma Corporation |
Beardsley, Robert Alan
4 - Director of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-502,218.99
-99,057 vol $5.07 each |
32,276 | |
| Filed 2026-09-23 21:54 Tx date 2026-09-18 |
$ABUS
Arbutus Biopharma Corporation |
Beardsley, Robert Alan
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$168,105
+52,533 vol $3.20 each |
131,333 | |
| Filed 2026-09-23 21:53 Tx date 2026-09-18 |
$ABUS
Arbutus Biopharma Corporation |
Beardsley, Robert Alan
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$334,112
+78,800 vol $4.24 each |
78,800 | |
| Filed 2026-09-23 21:53 Tx date 2026-09-18 |
$ABUS
Arbutus Biopharma Corporation |
Beardsley, Robert Alan
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-168,105.60
-52,533 vol $3.20 each |
105,067 | |
| Filed 2026-09-23 21:52 Tx date 2026-09-18 |
$ABUS
Arbutus Biopharma Corporation |
Beardsley, Robert Alan
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-334,112
-78,800 vol $4.24 each |
157,600 | |
| Filed 2026-06-11 06:45 Tx date 2026-06-08 |
$ABUS
Arbutus Biopharma Corporation |
Beardsley, Robert Alan
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$334,112
+78,800 vol $4.24 each |
236,400 | |
| Filed 2025-03-20 18:10 Tx date 2025-03-18 |
$ABUS
Arbutus Biopharma Corporation |
Beardsley, Robert Alan
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$504,320
+157,600 vol $3.20 each |
157,600 | |
| Filed 2025-03-06 16:41 Tx date 2025-02-25 |
$ABUS
Arbutus Biopharma Corporation |
Beardsley, Robert Alan
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-03-06 16:41 Tx date 2025-02-25 |
$ABUS
Arbutus Biopharma Corporation |
Beardsley, Robert Alan
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||